ClinConnect ClinConnect Logo
Search / Trial NCT06278883

Genomic Medicine Risk Assessment Care for Everyone - Implementation Phase

Launched by DUKE UNIVERSITY · Feb 19, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Implementation Science Risk Assessment Genetics Cascade Screening Family History Hereditary Conditions Genetic Testing Genetic Counselling

ClinConnect Summary

The "Genomic Medicine Risk Assessment Care for Everyone" (GRACE) trial is focused on improving health care for people at risk of cardiovascular diseases, cancer, liver diseases, and other conditions, especially in areas with fewer resources. The goal is to create a system that helps doctors assess genetic risks and provide better care to their patients. By involving patients, their family members, and healthcare providers, the trial aims to make genomic medicine more accessible and effective for everyone.

To participate, you need to be at least 18 years old, receiving care at one of the five participating clinics, and comfortable using the Internet in English. If you join, you will fill out a survey about your health and family history, and you may receive genetic testing based on your risk assessment results. Your healthcare provider will also be involved, receiving updates about your risk assessment. This study aims to reduce health disparities and improve health outcomes for individuals and families by tailoring the program to fit different needs and resources.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Receiving primary medical care in one of the 5 participating clinics
  • Age 18 years or older
  • Able to read and communicate in English
  • Able to provide written and verbal informed consent
  • Willing to use the Internet
  • Exclusion Criteria:
  • Anyone not meeting inclusion criteria
  • Previous genetic counseling and/or previous hereditary panel testing

About Duke University

Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.

Locations

Callahan, Florida, United States

Jacksonville, Florida, United States

Jacksonville, Florida, United States

Jacksonville, Florida, United States

Jacksonville, Florida, United States

Jacksonville, Florida, United States

Jacksonville, Florida, United States

Orange Park, Florida, United States

Patients applied

0 patients applied

Trial Officials

Lori Orlando, MD

Principal Investigator

Duke University

Alexander S Parker, PhD

Principal Investigator

University of Florida

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported